Pan-cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment.
Tao JiangQingzhu JiaWenfeng FangShengxiang RenXiaoxia ChenChunxia SuLi ZhangCaicun ZhouPublished in: Clinical and translational medicine (2020)